Diarrhea News and Research

RSS
Diarrhea is loose, watery stools. A person with diarrhea typically passes stool more than three times a day. People with diarrhea may pass more than a quart of stool a day. Acute diarrhea is a common problem that usually lasts 1 or 2 days and goes away on its own without special treatment. Prolonged diarrhea persisting for more than 2 days may be a sign of a more serious problem and poses the risk of dehydration. Chronic diarrhea may be a feature of a chronic disease.

Diarrhea can cause dehydration, which means the body lacks enough fluid to function properly. Dehydration is particularly dangerous in children and older people, and it must be treated promptly to avoid serious health problems.
FDA approves first vaginal ring contraceptive that can be used for one year

FDA approves first vaginal ring contraceptive that can be used for one year

New study investigates whether nicotine could slow memory loss

New study investigates whether nicotine could slow memory loss

FDA approves potassium chloride oral solution as first generic drug to receive CGT designation

FDA approves potassium chloride oral solution as first generic drug to receive CGT designation

FDA approves drug for rare, hard-to-treat types of non-Hodgkin lymphoma

FDA approves drug for rare, hard-to-treat types of non-Hodgkin lymphoma

Probiotic use could result in disorienting brain fogginess and rapid belly bloating

Probiotic use could result in disorienting brain fogginess and rapid belly bloating

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

FDA approves first drug for treatment of adult AML patients with specific genetic mutation

FDA approves first drug for treatment of adult AML patients with specific genetic mutation

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

Scientists identify melanoma biomarkers that could help tailor immunotherapy treatments

Scientists identify melanoma biomarkers that could help tailor immunotherapy treatments

FDA grants approval for first breast cancer drug through 'Real-Time Oncology Review'

FDA grants approval for first breast cancer drug through 'Real-Time Oncology Review'

Olfactory receptors perform a range of unknown functions outside the nose, reveals study

Olfactory receptors perform a range of unknown functions outside the nose, reveals study

Scientists elucidate how E.coli bacteria attach to host intestinal epithelium

Scientists elucidate how E.coli bacteria attach to host intestinal epithelium

Breastfeeding makes babies smarter and saves money

Breastfeeding makes babies smarter and saves money

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

Geriatric assessments could fine-tune cancer care for older adults

Geriatric assessments could fine-tune cancer care for older adults

FDA approves cannabis based drug for severe form of epilepsy

FDA approves cannabis based drug for severe form of epilepsy

Researchers discover immune cells that create and sustain chronic inflammatory bowel disease

Researchers discover immune cells that create and sustain chronic inflammatory bowel disease

Research provides new target to help treat chemotherapy-induced diarrhea

Research provides new target to help treat chemotherapy-induced diarrhea